Elena Santagostino

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 11

Top Topics

Postoperative Pain

Ejection Fraction

Peritoneal Dialysis

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

This page only lists publications with an associated author ORCID identifier.

Publications

Silvia Riva, Emanuela Marchesini, Emily Oliovecchio, Antonio Coppola, Elena Santagostino, Paolo Radossi, Giancarlo Castaman, Lelia Valdrè, Cristina Santoro, Annarita Tagliaferri, Cosimo Pietro Ettorre, Ezio Zanon, Giovanni Barillari, Isabella Cantori, Teresa Maria Caimi, Gianluca Sottilotta, Alfonso Iorio, Pier Mannuccio Mannucci
Comparison of quality of life, and emotional and functional profiles in older people with and without severe haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia 27 (4) (2021)
Elena Santagostino, Shadan Lalezari, Mark T Reding, Jonathan Ducore, Heng Joo Ng, Lone H Poulsen, Lisa A Michaels, Camila Linardi
Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during minor surgical procedures in patients with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 27 (4) (2021)
Victor Jimenez Yuste, Günter Auerswald, Gary Benson, Gerry Dolan, Cedric Hermans, Thierry Lambert, Rolf C R Ljung, Massimo Morfini, Elena Santagostino, Silva Zupančić Šalek
Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Alberto Tosetto, Anne Neff, Steven R Lentz, Elena Santagostino, Laszlo Nemes, Jameela Sathar, Karina Meijer, Pratima Chowdary, Chunduo Shen, Andrea Landorph, Kingsley Hampton
Turoctocog alfa pegol provides effective management for major and minor surgical procedures in patients across all age groups with severe haemophilia A: Full data set from the pathfinder 3 and 5 phase III trials. Haemophilia : the official journal of the World Federation of Hemophilia 26 (3) (2020)
Alok Srivastava, Elena Santagostino, Alison Dougall, Steve Kitchen, Megan Sutherland, Steven W Pipe, Manuel D Carcao, Johnny N Mahlangu, Margaret V Ragni, Jerzy Windyga, Adolfo Llinás, Nicholas J Goddard, Richa Mohan, Pradeep Mathew Poonnoose, Brian M Feldman, Sandra Zelman Lewis, H Marijke van den Berg, Glenn F Pierce, null null
WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia : the official journal of the World Federation of Hemophilia (2020)
Maria Elisa Mancuso, Johannes Oldenburg, Lisa Boggio, Gili Kenet, Anthony Chan, Carmen Altisent, Wilfried Seifert, Elena Santagostino
High adherence to prophylaxis regimens in haemophilia B patients receiving rIX-FP: Evidence from clinical trials and real-world practice. Haemophilia : the official journal of the World Federation of Hemophilia 26 (4) (2020)
Riana Liesner, Nadine G Andersson, Tony Frisk, Elena Santagostino, Martin Schulz, Lisa Young, Paola Giordano, Annarita Tagliaferri
Safety and efficacy of nonacog alfa for the treatment of haemophilia B in children younger than 6 years of age in a routine clinical care setting: the EUREKIX registry study. Haemophilia : the official journal of the World Federation of Hemophilia 27 (1) (2020)
Cedric Hermans, Shashikant Apte, Elena Santagostino
Invasive procedures in patients with haemophilia: Review of low-dose protocols and experience with extended half-life FVIII and FIX concentrates and non-replacement therapies. Haemophilia : the official journal of the World Federation of Hemophilia (2020)
Charles R M Hay, Midori Shima, Michael P Makris, Victor Jiménez-Yuste, Johannes Oldenburg, Kathelijn Fischer, Alfonso Iorio, Mark W Skinner, Elena Santagostino, Sylvia von Mackensen, Craig M Kessler
Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
Elena Santagostino, Gili Kenet, Kathelijn Fischer, Tina Biss, Sanjay Ahuja, MacGregor Steele
PROTECT VIII Kids: BAY 94-9027 (PEGylated Recombinant Factor VIII) safety and efficacy in previously treated children with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 26 (3) (2020)
Mark T Reding, Ingrid Pabinger-Fasching, Shadan Lalezari, Elena Santagostino, Maria Elisa Mancuso
Target joint resolution in patients with haemophilia A receiving long-term prophylaxis with BAY 94-9027. Haemophilia : the official journal of the World Federation of Hemophilia 26 (4) (2020)